首页 | 本学科首页   官方微博 | 高级检索  
检索        

血浆纤维蛋白原与2型糖尿病患者下肢血管病变的关系
引用本文:许金秀,李新胜,李佳芮,张金成,王光亚,李玉坤.血浆纤维蛋白原与2型糖尿病患者下肢血管病变的关系[J].临床荟萃,2010,25(6):492-494.
作者姓名:许金秀  李新胜  李佳芮  张金成  王光亚  李玉坤
作者单位:河北医科大学第三医院内分泌科,河北 石家庄 050051;沧州市中心医院内分泌科,河北 沧州 061001%沧州市中心医院内分泌科,河北 沧州,061001%河北医科大学第三医院内分泌科,河北 石家庄,050051
基金项目:河北省重大疾病和常见病预防治疗关键技术专项基金,河北省科技支撑计划项目
摘    要:目的 探讨血浆纤维蛋白原(FIB)水平与2型糖尿病患者下肢血管病变相关性.方法 选择2型糖尿病患者240例,男132例,女108例,全部受试者均采用高分辨彩色多普勒超声检查判定下肢动脉病变程度,按下肢血管病变严重程度进行评分,所有入选病例分为2型糖尿病下肢血管病变组(病变组又分为轻度、中度和重度组)与非病变组,比较病变组与非病变组间血浆纤维蛋白原水平;同时根据纤维蛋白原水平,比较高纤维蛋白原水平和正常纤维蛋白原水平患者的下肢血管病变发生率及病变严重程度情况.结果 糖尿病下肢血管病变组纤维蛋白原水平显著高于非病变组(3.20±0.66)g、L VS(2.85±0.57)g、L(P<0.01),高纤维蛋白原患者较正常纤维蛋白原的下肢血管病变发生率显著增加,病变程度更重(50.94%VS 26.20%,P<0.05).结论 血浆纤维蛋白原升高是2型糖尿病下肢血管病变的重要危险因素之一.

关 键 词:糖尿病:2型  糖尿病肾病  T淋巴细胞亚群  炎症  

Relation between blood fibrinogen and lower extremity vasculopathy in type 2 diabetic patients
XU Jin-xiu,LI Xin-sheng,LI Jia-rui,ZHANG Jin-cheng,WANG Guang-ya,LI Yu-kun.Relation between blood fibrinogen and lower extremity vasculopathy in type 2 diabetic patients[J].Clinical Focus,2010,25(6):492-494.
Authors:XU Jin-xiu  LI Xin-sheng  LI Jia-rui  ZHANG Jin-cheng  WANG Guang-ya  LI Yu-kun
Institution:1. Department of Endocrinology ,the Third Hospital of Hebei Medical University ,Shijiazhuang 050051 ,China ;2. Department of Endocrinology, Cangzhou Central Hospital, Cangzhou 061001, China)
Abstract:Objective To investigate the association of blood fibrinogen and lower extremity vasculopathy in type 2 diabetic patients. Methods 240 patients diagnosed type 2 diabetes mellitus included 132 males and 108 females were chosen. All of them received high-resolution color Doppler ultrasonography of lower extremity arteries, and the score was counted. According to the degree of lower extremity vasculopathy, the patients were divided into lower extremity vasculopathy group and non-diseased normal group. Among the lower extremity vasculopathy group, the patients were then divided into mild, midrange and severe group. Furthermore, the prevalence and the process severity of lower extremity vasculopathy were compared in the high and normal blood fibrinogen groups. Results The level of blood fibrinogen in the lower extremity vasculopathy group was significantly higher than that in non-diseased normal group (3.20±0.66) g/L vs (2.85±0.57) g/L( P 〈0.05). Compared with that of normal blood fibrinogen group,the prevalence of lower extremity vasculopathy was increased and the disease severity was more serious in the lower extremity vasculopathy group (50.94% vs 26.20%, P 〈0.05). Conclusion The increased blood fibrinogen is one of the important risk factors in lower extremity vasculopathy with type 2 diabetic patients.
Keywords:diabetes mellitus  type 2  fibrinogen  diabetic angiopathies
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《临床荟萃》浏览原始摘要信息
点击此处可从《临床荟萃》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号